Abiopharma

News list

📋 NIKHIL LALWANI (Director) plans to sell 5K shares of ANI PHARMACEUTICALS, INC (at $74.17 each, total $401K) Filed: Aug 25, 2026 | ID: 008689

Full text

News bot Aug. 25, 2026, 8:43 p.m.
📋 Form 144 Filing: NIKHIL LALWANI

Company: ANI PHARMACEUTICALS, INC

Filing Date: 2026-08-25

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 5,400
- Price per Share: $74.17
- Total Value: $400,518.00
- Planned Sale Date: 2026-08-25
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-31812
- Issuer Contact Phone: (609)759-1810
- Issuer Address: 104 Carnegie Center Drive, Suite 300, Princeton, NJ, 08540
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 22959000.0
- Number of Securities to be Sold: 1
- Signature: /s/ Nikhil S Lalwani
- Plan Adoption Dates: 2026-05-26